The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(Cyclopropanecarbonylamino)-1-(3-methylbenzoyl)-1H-indazole-3-carboxylic Acid Ethyl Ester ID: ALA2409575
PubChem CID: 71818964
Max Phase: Preclinical
Molecular Formula: C22H21N3O4
Molecular Weight: 391.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1nn(C(=O)c2cccc(C)c2)c2ccc(NC(=O)C3CC3)cc12
Standard InChI: InChI=1S/C22H21N3O4/c1-3-29-22(28)19-17-12-16(23-20(26)14-7-8-14)9-10-18(17)25(24-19)21(27)15-6-4-5-13(2)11-15/h4-6,9-12,14H,3,7-8H2,1-2H3,(H,23,26)
Standard InChI Key: ADRQRUHQDUYTFF-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
17.6095 -3.8837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6083 -4.7032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3164 -5.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3146 -3.4748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0232 -3.8801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0235 -4.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8047 -4.9601 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2901 -4.2913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8057 -3.6261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7911 -5.7758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0760 -6.1714 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4912 -6.1972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4740 -7.0130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1734 -7.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8894 -7.0387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9017 -6.2173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2018 -5.7997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1800 -2.8997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9962 -2.8606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4382 -3.5480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7380 -2.2123 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6154 -5.8192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2544 -3.5089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9017 -3.4753 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1941 -3.8840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4862 -3.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1942 -4.7012 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0814 -2.7668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6730 -3.4746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
18 19 1 0
19 20 1 0
18 21 2 0
16 22 1 0
20 23 1 0
1 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
28 26 1 0
29 28 1 0
26 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.43Molecular Weight (Monoisotopic): 391.1532AlogP: 3.56#Rotatable Bonds: 5Polar Surface Area: 90.29Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.73CX Basic pKa: ┄CX LogP: 3.55CX LogD: 3.55Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.67Np Likeness Score: -1.79
References 1. Crocetti L, Schepetkin IA, Cilibrizzi A, Graziano A, Vergelli C, Giomi D, Khlebnikov AI, Quinn MT, Giovannoni MP.. (2013) Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase., 56 (15): [PMID:23844670 ] [10.1021/jm400742j ]